Tuesday, October 8, 2024

CustomerInsights.AI in Gartner® Hype Cycle™ 2024

Related stories

Credo AI Launches Integrations Hub

Credo AI, the global pioneer of the AI governance...

Drone Nerds Adds Deepthink S8 Low-Light Camera to Its Enterprise Lineup

Drone Nerds, one of North America’s largest retailers, distributors,...

TurboDocx Writer Now Available on Microsoft AppSource

TurboDocx, a leading provider of AI-powered document generation solutions,...

Baker Tilly Acquires Alirrium, Expanding RPA and AI Capabilities

Leading advisory, tax and assurance firm Baker Tilly is...

OVHcloud and F5 Deliver Advanced Multicloud Application Security

OVHcloud® US, a global cloud player and leading European cloud...
spot_imgspot_img

CustomerInsights.AI has once again been recognized in the Gartner Hype Cycle for Life Science Commercial Operations, 2024. This marks the second consecutive year CustomerInsights.AI has been included in the Data and Analytics (D&A) Platforms in Commercial Life Sciences category. We believe, this recognition underscores our commitment to pioneering advancements in technology and innovation within the life sciences industry.

According to Gartner, “Life science organizations (LSOs) — encompassing pharmaceutical, biotechnology and medical device sectors — are undergoing transformative shifts to achieve top enterprise goals of operational efficiency, business growth and regulatory compliance (see Life Science 2024 CIO Agenda Insights and Data).”. In our opinion, this recognition reflects our dedication to driving innovation and excellence in the life sciences industry. We look forward to continuing to lead the way in transforming commercial operations through cutting-edge technology.

Abhay Jajoo, CEO of CustomerInsights.AI, says “We are once again proud to have been recognized in the Gartner Hype Cycle™ for Life Science Commercial Operations, 2024, which we think reaffirms the impact of our platform-led approach at CIAI. ciPARTHENON™ continues to deliver significant business value for our Life Sciences customers, helping them achieve faster results at lower costs. We believe this mention for 2024 underscores our commitment to innovation that truly matters – advancing technological maturity and driving business outcomes. We remain dedicated to pushing the boundaries of what’s possible.”

Also Read: Gilead & Genesis Partner to Develop Novel Therapies

As noted by Gartner, “Commercial D&A platforms streamline data management processes with robust industry- specific capabilities for data ingestion, data quality tracking and data governance on a prebuilt commercial operations data model. These platforms give business users and data scientists more control by enabling data access through advanced capabilities (such as an interactive information portal, an analytical workbench and a data science laboratory).”

Our Commercial Analytics Cloud – ciPARTHENON™ helps integrate key Marketing & Customer Engagement applications such as Omnichannel management, Social & GenAI Intelligence, and Next Best Action. This integration delivers a cohesive and intelligent customer experience, enabling organizations to effectively manage and enhance their customer relationships.

CustomerInsights.AI‘s advanced integration of generative AI (GenAI) and analytics has set new standards for operational efficiency and customer engagement. Our technologies are pivotal in driving personalization, optimizing market access, improving patient engagement, and leveraging data analytics. These areas reflect the evolving needs of Life Science Organizations(LSOs) to adapt to new challenges and opportunities.

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img